An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder
Completed · Not applicable
Conditions studied: Bulimia Nervosa, Body Dysmorphic Disorder
In brief
The primary objective of this 13-week clinical trial is to test the hypothesis that treatment with Memantine will significantly improve the symptoms of those suffering from either bulimia nervosa, purging type or suffering from body dysmorphic disorder.
Key facts
- Study ID
- NCT01038128
- Run by
- Mclean Hospital
- People needed
- 5
- Starts
- 2009-12-01
- Expected to finish
- 2011-05-01
- Last updated by the study team
- 2015-05-04
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- McLean Hospital — Belmont, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.